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Abstract: Neoplasia is a literal translation of the Greek word “new growth’. Neoplastic cells are said to be
transformed because they replicate continuously, heedless and in perfect asynchronism to the regulatory
influences that govern normal cell growth. As a result, a fundamental characteristic of neoplasms is the loss
of responsiveness to regular growth control resulting from failure of the usual mechanisms that control cellular
proliferation and maturation. Moreover, this random growth continues even in the absence of the stimulus. In
this study, the cellular, molecular and biochemical mechanisms of carcinogenesis are analysed. This entails a
detailed discussion of the cell cycle and its fine regulation together with an explanation of the link between the
cell cycle and induction of cancer. Proto-oncogenes and tumor-suppressor genes are also discussed. Finally,
the genetic aspect of cancer is tackled.
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INTRODUCTION delve  into  the  molecular  mechanisms that tune normal
Neoplasm, as defined by Rupert Willis, is an proliferation in healthy cells? This is the fundamental
abnormal mass of tissue, the growth of which is dogma which must be answered before proceeding to
uncoordinated with that of normal tissues and that understand the molecular mechanisms which induce
persists in the same excessive manner after the cessation neoplastic growth and enhance its proliferation. This
of the stimulus which evoked the change (APQUB, 2003). question arises naturally since before proceeding to
Neoplastic cells are said to be transformed because understand the abnormal, one must know thoroughly the
they replicate continuously, heedless and in perfect normal.
asynchronism to the regulatory influences that govern A cell is an autonomous unit. All the instructions
normal cell growth. As a result, a fundamental needed to direct its activities are contained within its
characteristic of neoplasms is the loss of responsiveness DNA  (Deoxyribonucleic  Acid)  located  in the nucleus.
to regular growth control resulting from failure of the As already stated, cells are continuously dividing into
usual mechanisms that control cellular proliferation and new cells referred to as daughter cells. This is vital to
maturation. Moreover, this haphazardous growth replace the lost cells. The chain of events occurring in
continues in the absence of the stimulus, contrasting eukaryotic cells between one cell division and the next
sharply with hyperplasia in which growth cessation which therefore encompasses DNA replication is referred
ensues on removal of the stimulus involved (Stevens and to as the cell cycle. This is exclusive to eukaryotic
Lowe, 2000). organisms.
THE CELLULAR, MOLECULAR AND stages and check points with each stage being dominated
BIOCHEMICAL MECHANISMS OF by a particular event taking place in the cell. 
CARCINOGENESIS The G  phase or first gap phase precedes replication.
As previously alluded to, neoplastic growth is phase, the commitment to divide is triggered in a still not
characterized by a state of unregulated cell growth. A known way. Synthesis of histones is one of the first
neoplasm has nothing to do with an infectious disease signals of incipient DNA replication since division
induced by a microorganism- it is simply a cell that all of requires doubling of the DNA content which in turn
a sudden has been transformed. Therefore, it is crucial to requires new histones for the production of chromatin. 
cell growth in healthy cells. What governs regular cell
The eukaryotic cell cycle is divided into various
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Fig. 1a: The main stages of the cell cycle
Fig. 1b: Changes in DNA content throughout the
various stages of the cell cycle
The cell then enters the S phase or synthesis phase.
During this period, replication of the DNA proceeds and
the histones and non-histone proteins are deposited on
the daughter DNA molecules to produce chromatin.
When replication is complete, the cell enters the G  or2
Gap  phase. At this stage, the cell has DNA content four2
times the haploid amount. In most eukaryotic cells, the
total time required for G , S and G  phases will be many1    2
hours but this obviously is highly variable. 
During this entire period known as interphase, the
chromatin is dispersed throughout the nucleus, being
actively engaged in transcription. At the end of the G2
phase, the cell is prepared to start mitotic division and this
is known as the M phase which is in turn divided into
prophase, metaphase, anaphase and telophase ending in
cytokinesis.
Figure 1 (a and b) are two representations of the
eukaryotic cell cycle, showing the various phases just
mentioned above. Figure 1a shows an overview of the
different stages of the cell cycle while Fig. 1b includes
some details of what happens at each stage as well as the
approximate average duration of the various stages.
In prophase, the chromosomes become condensed
and the nuclear envelope breaks down. This is followed
by metaphase where the chromosomes come to lie in the
equatorial plane and mitotic spindles are clearly evident.
During anaphase, the chromatids are pulled to opposite
sides of the pole so that each daughter cell possesses one
sister chromatid. Telophase is the reverse of prophase
where the chromosomes exit their condensed form and
become loose again and the nucleolus and nucleus
reform. Cytokinesis is produced by invagination of the
cell membrane via furrowing yielding two daughter cells.
After passing through mitosis into the G  phase, the1
cell either continues the process, resulting in another cell
division or else if it ceases to divide, it enters a quiescent
phase known as the G  stage. This stage has a variable0
duration and it may last from hours to days all the way up
to the lifetime of the cell. Cells such as neurons which do
not divide remain in the G  phase.0
REGULATION OF THE CELL CYCLE
After understanding what the cell cycle is and its
main stages and events taking place in each phase, a
crucial question that arises is: How is the cell cycle
regulated?
The cell makes two important all-or-none decisions
during the cell cycle: the first decision is taken late in the
G  stage and concerns the entry into the S phase. DNA1
replication should initiate only when the cell is prepared
to progress through the entire cell cycle and it should
embark only after any DNA damage sustained during the
preceding stages has been thoroughly repaired via DNA
repair mechanisms.
The second all-or-none decision regards the entry
into mitosis. Mitosis should proceed only after the
completion of DNA replication and only if the replicated
chromosomes are structurally intact. Once initiated
mitosis proceeds through all the stages (Nelson and Cox,
2000).
These two all-or-none decisions define the G1
checkpoint and the G  checkpoint, respectively.2
The regulation of the cell cycle depends on the
interaction of two basic proteins, namely Cyclin-
Dependent Kinases (CDKs) and a group of regulatory
proteins called cyclins which orchestrate the metabolic
activities of the cell to produce orderly and tightly
controlled cell division. As their name implies, cyclin
dependent kinases are only active when bound to the
respective cyclin. Cyclin concentrations are in turn
regulated by synthesis and degradation.
Res. J. Med. Sci., 2 (2): 77-84, 2008
79
The activity of cyclin dependent kinases during the
progression of the cell cycle is regulated by a number of
molecular mechanisms.
The first level of regulation involves the association
of cyclin dependent kinases with their cyclin partners.
The formation of specific CDK-cyclin complexes is tuned
by cyclin degradation and synthesis as previously
alluded to.
Activation of the CDK-cyclin complex requires
phosphorylation of a conserved threonine residue around
position 160. Phosphorylation of a different amino acid
which is tyrosine will inhibit the cyclin dependent
kinase’s activity. Dephosphorylation of these tyrosine
residues is required in order to switch the cyclin
dependent kinases back to their active state.
The activity of cyclin dependent kinases is also
controlled by the binding of inhibitory proteins known as
CDK Inhibitors (CDKI). Control of these inhibitors thus
provides an additional mechanism by which the activity
of cyclin dependent kinases is controlled.
Growth factors and cytokines also play a role in
regulating the synthesis of cyclins and cyclin dependent
kinases. These have the potential to transducer gene
induction, proliferation or programmed cell death, that is,
apoptosis. Growth factors result ultimately in cell division
thru an enzyme cascade that activates MAPK (Mitogen-
Activated Protein Kinase) by which transcription factors
such as Jun and Fos are phosphorlylated, thus activating
the transcription factor E2F, which enhances the
production of enzymes crucial for DNA replication as well
as activating transcription of cyclin D, cyclin E, CDK2 and
CDK4. The role of growth factors is illustrated in Fig. 2.
Mitogenic growth factors are important between the
onset of the G  phase and a point later in the G  phase1        1
known as the restriction point beyond which the
remaining phases of the cell cycle are not under the
influence of extracellular signals and are committed to
progress rather than quiesce.
The combined effects of these multiple modes of
cyclin dependent kinases regulation are responsible for
controlling the course of the cell cycle in response to both
the checkpoint controls and to a variety of other
extracellular stimuli that influence cell proliferation.
In eukaryotic cells Cdc2 is also known as CDK-1
which together with cyclins A and B control mitosis.
After having discussed the control mechanisms
which govern the activity of cyclin dependent kinases, it
is worth looking in detail at the structure of these kinases
and how this structure enables them to subserve their
function.
Fig. 2: Regulation of cell division by growth factors
(Nelson and Cox, 2000)
CDK-cyclin complexes can be considered as
heterodimers with a regulatory subunit, cyclin and a
catalytic subunit, Cyclin-Dependent protein Kinase
(CDK). In the absence of cyclin, the catalytic subunit is
virtually inactive (Wikipedia, 2006). When cyclin binds,
the catalytic subunit opens up, a residue essential for
catalysis is accessible and the activity of the catalytic
subunit increases about 10,000 fold (Nelson and Cox,
2000).
Animal cells have at least ten different cyclins
(designated A,B, etc) and at least 8 Cyclin-Dependent
Kinases (CDK 1-8) which act in various combinations at
different stages throughout the cell cycle. Certain cyclin
dependent kinase activities exhibit striking oscillations as
is portrayed in a population of animal cells undergoing
synchronous cell division. This results from the four
major mechanisms regulating cyclin dependent kinase
activity namely whether it is phosphorlylated or
dephosphorylated; the degradation of the cyclin subunit;
phasic synthesis of the respective cyclin dependent
kinases and cyclins and the effect of cyclin dependent
kinases specific inhibitors.
Each transition in the cell cycle has a unique cyclin-
kinase complex as its trigger. For instance, the complex
cyclin E-CDK2 activity peaks near the G  phase-S phase1
boundary where the active enzyme triggers synthesis of
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enzymes required for DNA synthesis. On the other hand, The next question that stems out is: How does CDK
cyclin A-CDK2 complex is dominant during the S phase activity control the cell cycle?
and G  phase and then dwindles down in the M phase Cyclin dependent kinases regulate cell division by2
where cyclin B-CDK1 peaks. These oscillations are phosphorylation of critical proteins. 
illustrated in Fig. 3.
There is a feedback loop in which increased cyclin
dependent kinase activity turns on cyclin proteolysis.
Newly synthesized cyclin activates cyclin dependent
kinase by associating with it and this, in turn, activates
DBRP (Destruction Box Recognition Protein) by
phosphorylating it. Active DBRP then induces
prtoteolysis of cyclin. It does this by causing the
attachment of ubiquitin molecules to cyclin by the enzyme
ubiquitin ligase. Hence, it is the cyclin-CDK complex itself,
which via negative feedback, triggers its own inactivation.
Lowered cyclin concentrations on the other hand causes
cyclin dependent kinase activity to decrease, lowering
down the activity of DBRP also drops through slow
constant dephosphorylation and inactivation by a DBRP Fig. 3: A   unique    cyclin-kinase    complex   is  needed
phosphatase. Synthesis of new cyclin molecules helps to for each stage of the cell cycle (Nelson and Cox,
restore the cyclin level. This is summarized in Fig. 4. 2000)
Fig. 4: The feedback loop involved in the regulation of cyclins (Nelson and Cox, 2000)
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Fig. 5: The role of Retinoblastoma protein (pRb) in the (Lodish et al., 2000).
regulation of cell division (Nelson and Cox, 2000) Incidentally, also quite recently, the field of molecular
Phosphorylation, as part of a control mechanism, is science together with the molecular mechanisms of the
reflected in all major physiological mechanisms and keeps cell cycle have merged together to shed light on the
on repeating itself as a means by which a variety of atielogy of cancer and its pathophysiology. In fact,
proteins and molecules are activated. genetic alterations play a significant role in the alteration
The targets of cyclin dependent kinases are many of the normal cell cycle mechanisms and therefore cause
and include laminin, myosin and Retinoblastoma protein a cell to undergo malignant change. Two main types of
(pRb) amongst others. genetic alterations have been identified, involving either
Laminin is vital for the cytoarchitecture and in fact mutations which cause activation of function or else
highly organized meshworks of intermediate filaments mutations which cause loss of function of certain genes.
composed of laminin are a requisite for the structure of the
nuclear envelope. It follows then, that breakdown of the GAIN-OF-FUNCTION MUTATIONS:
nuclear envelope in the prophase stage of mitosis is due THE PROTO-ONCOGENES
to depolymerisation of laminin filaments. It is partly due to
the phosphorlyation of laminin by a particular cyclin The conversion of proto-oncogenes into oncogenes
dependent kinase that this disorganization of laminin portrays an example of a gain-of- function mutation. The
takes place. products of these proto-oncogenes are crucial for cellular
During cytokinesis, the cell membrane undergoes signaling and the ordered progression through the cell
furrowing. This requires an ATP-driven actomyosin cycle and cell division. Their vital roles are reflected in the
contractile machinery. Once cell division has taken place, fact that they have been highly conserved throughout
it is the cyclin dependent kinase that phosphorylates a evolution. It follows that if a proto-oncogene undergoes
small regulatory subunit of myosin, separating myosin a somatic mutation, cell growth and proliferation become
from actin filaments and thus inactivating the contractile erratic and thus malignant change ensues (Mueller and
machinery. Young, 2002).
Retinoblastoma protein (pRb) functions in all cell An oncogene codes for a protein which has the
types as a surveillance system which controls cell capacity to induce unrestrained growth and trigger
division in response to various stimuli. When in the neoplasia. Although some oncogenes are derived from
unphosphorylated state, pRb binds to the transcription mutated proto-oncogenes, one must bear in mind that
factor E2F and in this state, E2F fails to trigger only a small part fall into this category (Lodish et al.,
transcription of the enzymes required for the synthesis of 2000).
DNA and thus the cell cycle remains in the G1 stage The ras gene, for example, is a proto-oncogene that
without embarking on to the S phase. The complex cyclin codes for an intracellular signal-transduction protein.
E-CDK2 phosphorylates pRb and so cell division can go
on since the blocking effect is eliminated. Figure 5
summarises the role of pRb.
THE LINK BETWEEN THE CELL
CYCLE AND CANCER
Both the cell cycle and cancer are extremely
interesting scientific fields which only recently have had
their molecular mechanisms unraveled. However, the
overlap that exists between cancer and cell cycle is even
much more alluring than the above 2 aspects of science
independently. Even at first glance, the link between cell
cycle and cancer is obvious. As described above, the cell
cycle is the guard which controls normal cell division and
proliferation while in cancer it is exactly this that has
become abnormal. In fact, it is said that normal growth
control and malignancy are two faces of the same coin
genetics is rapidly gaining ground as well. This aspect of
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Therefore, when this gene undergoes a mutation and translation of the c-myc gene which is important for the
hence become an oncogene, the oncoprotein it produces, production of proteins concerned in the control of the cell
leads to abnormal growth (Lodish et al., 2000). cycle. The proviral DNA can act as a promoter or an
The process of activating a proto-oncogene into an enhancer of c-myc transcription resulting in a perfectly
oncogene via a gain-of-function mutation involves a normal expressed protein but produced at much higher
number of different mechanisms. Three mechanisms are concentrations which accounts for the induction of
believed to play a role in this change. These mechanisms neoplasia. Moreover, the proviral DNA prevents
involve either point mutations in the proto-oncogene that downregulation of the protein and thus cells instead of
code for an active protein or duplication of a particular differentiating, keep on proliferating. These slow-acting
part of DNA resulting in multiple copies of the same gene, viruses are much more common than the fast-acting
leading to increased translation of the protein or else they viruses which possess an oncogene (Lodish et al., 2000).
involve a chromosomal translocation which results in a Apart from retroviruses, DNA-containing viruses are
change in the promoter of the gene resulting in abnormal also potential triggers of neoplasia. A classical example is
translation of the gene. As is conveyed through these the Human Papilloma Virus (HPV) which causes warts and
different mechanisms, oncogenes are either mutated benign tumors in the epithelium.
proto-oncogenes or else proto-oncogenes expressed at
abnormal levels (Lodish et al., 2000; Mueller and Young, LOSS-OF-FUNCTION MUTATIONS:
2002). TUMOR SUPPRESSOR GENES
Contrary to tumor suppressor genes which will be
dealt with later on, mutation in only one of the alleles is The second type of mutations responsible for
enough to induce neoplastic growth (Lodish et al., 2000). induction of neoplastic growth are the loss-of-function
In 1911 Peyton Rous conducted a series of studies mutations as opposed to those mentioned above which
that eventually introduced the novel concept that viruses involve a gain of function. These classes of mutations
can induce cancer. The virus he worked with is known as involve what are known as tumor-suppressor genes.
Rous Sarcoma Virus (RSV) and fifty years later in 1966 his Tumor suppressor genes code for proteins that normally
concept was acknowledged and he was awarded the restrain unlimited cell division. Therefore, it is quite easily
Nobel Prize for this discovery (Lodish et al., 2000). As the conceivable that abnormalities in this gene result in
era  of  molecular  biology  set  in,  it was shown that RSV abnormal growth (Lodish et al., 2000; Mueller and Young,
is a retrovirus. This means that like HIV (Human 2002).
Immunodeficiency Virus) it has RNA (Ribonucleic Acid) Tumor suppressor genes code for 5 main classes of
as its genetic material and undergoes reverse transcription proteins, namely intracellular proteins such as the p16
using the enzyme reverse transcriptase to transform RNA cyclin-kinase inhibitor, p53, p21 and Retinoblastoma
into DNA. It was found that oncogenic transforming protein (pRb); receptors for secreted hormones such as
viruses such as RSV possess the v-src gene apart from TDGF $ (Tumor Derived Growth Factor $) that are crucial
other normal commonly found genes such as gag, pol and for preventing excess cell growth; check point control
env which encode for structural proteins for the core proteins that instantly stop the cell cycle if they detect
antigens, reverse transcriptase and glycoproteins in the any abnormalities; proteins that enhance programmed cell
envelope, respectively (Mueller and Young, 2002). It was death, that is apoptosis and also enzymes active in DNA
further unravelled that it is only the v-src gene that is repair mechanisms (Lodish et al., 2000).
responsible for neoplasia and not the other ones. It As can be seen tumor suppressor genes are crucial
causes abnormally high levels of v-src protein which for ensuring normal proliferation of cells and thus it is
results in aberrant phosphorylation of several proteins. At inevitable that defects in the proteins they code for, lead
this point the v-src gene was identified as an oncogene to neoplasia.
(Lodish et al., 2000). Unregulated growth due to defective tumor
As already alluded to, because of the possession of suppressor genes is genetically recessive. This means
the v-src  oncogene, RSV is able to trigger neoplasia and that unlike the v-src gene, tumors in this case, form only
it does so within days. However, most carcinogenic if both chromosomes of a pair are defective. An individual
retroviruses take a much longer time span to cause who inherits one correct copy and another effected copy
neoplastic growth. This stems from the fact that these will not be diseased, but has a higher risk of developing
slow acting or long latency retrovirus do not have an cancer since only one hit is needed to acquire 2 mutant
oncogene which directly enhances neoplasia. Hence, they alleles. Thus if any one of the 10 somatic cells
cause cancer via a different mechanism involving the subsequently acquires a mutation in the good copy, a
12 
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tumor will then grow from that doubly mutated cell. This longer inactivates E2F so that cell division is unrestricted.
highlights the fact that although one copy of a mutated Thus, it naturally follows that p53 is one of the major key
gene does not directly give rise to neoplasia, indirectly it proteins involved in tumor formation and proliferation
has the potential to do so in the long run, as it greatly (NCBI, 2006).
increases the risk of abnormal growths (Mueller and Experiments on knockout mice have revealed
Young, 2002). Nondisjunction and mitotic recombination interesting information. We have been faced with the
may play a role in producing a cell with two mutated gene concept that proteins like p53 not only regulate cell
copies which originally had only one mutated gene. This proliferation but also regulate apoptosis which is
event is known as Loss of Heterozygosity (Lodish et al., programmed cell death. This opens doors to new line of
2000). thoughts especially when it comes to devising drugs used
A classic case of loss of Heterozygosity which leads in chemotherapy. Maybe instead of manufacturing drugs
to abnormal function of pRB (retinoblastoma protein) is that inhibit or try to keep within control cell division, we
retinoblastoma which is a highly malignant childhood should  target  drugs  that enhance apoptosis so that
cancer of the retinal cells in the eye. Retinoblastoma can tumor cells are induced to program their own cell death
occur either sporadically without being inherited or else (Collins et al., 1997).
it is said to be familial, that is, inherited. Non-hereditary
cases occur in individuals who are born with two normal THE GENETIC ASPECT OF CANCER
alleles for retinoblastoma protein but have acquired
mutations in both the alleles. In these cases, the disease Although not all of the mutations in tumor
affects one eye and is very rare. In hereditary cases, suppressor genes or proto-oncogenes are inherited,
which are often bilateral, the individual inherits one mutations in these genes are commonly seen in cancers
defective allele and so has a high predisposition to that run in families. The inheritance of a mutant allele does
developing retinoblastoma. When he acquires a mutation not mean that the individual is going to develop cancer
in the only normal allele, then, he develops the disease. but predisposes the particular person to a greater risk
Thus retinoblastoma is an autosomal dominant trait than another one who has both of the alleles normal. A
(Lodish et al., 2000; Mueller and Young, 2002). typical example is inherited defects in the APC
This genetic predisposition to the premature onset of (Adenomatous polyposis coli) gene that are responsible
cancer is also highlighted in breast cancer which has been for Familial Adenomatous Polyposis (FAP), leading to the
linked to the tumor-suppressor gene known as BRCA1 formation of numerous colon polyps that could eventually
where woman who inherit one mutant BRCA1 allele run a become neoplastic (American Cancer Society, 2005;
60% risk for developing breast cancer as opposed to Mueller and Young, 2002). 
normal women having normal BRCA1 in both copies of It must be understood that the majority of colorectal
the genes which have merely a 2% chance of developing cancers are sporadic and in fact, only 1% of persons
breast cancer (Lodish et al., 2000). diagnosed with colorectal cancer have inherited the
Another tumor suppressor gene well studied by the defective APC gene. Similarly, a person who has
help of ‘gene knockout techniques’ apart from the pRb developed numerous polyps in his colon because of this
gene is the p53 gene. As with the pRb gene, inheritance gene, does not necessarily mean, that he will develop
of one abnormal copy of the gene predisposes the cancer because not all polyps undergo malignant change,
individual to formation of neoplasia. In fact, in rare cases, although the risk is quite high (Mueller and Young, 2002).
these individuals may present with several tumor growths The fact some of the cancers run in families and are
in different tissues; a condition known as Li-Fraumeni due to certain defective genes is the rationale behind
syndrome (Mueller and Young, 2002; NCBI, 2006). genetic testing. Genetic testing includes performing
The p53 gene is located on chromosome 17 and several tests to identify whether genes such as BRCA1
codes for the p53 protein which is a multimeric protein are present in the genome and thus advising the
that enhances the production of a protein called p21 individual about the risk of developing cancer. 
which  activates  which  is  a  CDK  inhibitor.  P21  can As can be concluded, cancer stems from a mutation
bind to and inhibit cyclinE-CDK2, thus preventing in a part of the DNA of the cell. Researchers studying
phosphorylation of pRb. Unphosphorylated pRb binds to cancer used to believe that carcinogenesis is caused
E2F and inactivates it, thereby preventing the progression solely by carcinogens such as cigarette smoke, chemicals
of the G1 phase to the S phase (NCBI, 2006). Mutant p53 or radiations. Others believed that it is an entirely genetic
leads to inavailability of the p21 to bind to and inhibit disease. However in the 1970s, as molecular biology
cyclinE-CDK2. Thus, pRb remains phosphorylated and no paced at a big step, scientists observed that all factors
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that in one way or another have the potential to trigger be synthesized in the future, which fortunately, will find
neoplasia, target the cell’s DNA and modify it. an answer to how to control cancer proliferation and if
Bert  Vogelstein,  an  HHMI  (Howard Hughes possible eradicate it.
Medical Institute) investigator at The Johns Hopkins
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